Top

Published in:

01-05-2010 | Original Article

Role of E-cadherin gene in gall bladder cancer and its precursor lesions

Authors: T. Padma Priya, V. K. Kapoor, N. Krishnani, Vinita Agrawal, Suraksha Agrawal

Published in: Virchows Archiv | Issue 5/2010

Abstract

The aim was to investigate the genomic instability in the E-cadherin (CDH1) gene and to correlate it with its protein expression in gall bladder cancer (GBC) and in other gall bladder (GB) diseases viz. chronic cholecystitis (CC), xantho-granulomatous cholecystitis (XGC), and normal GB to explicate its role in GBC tumorigenesis. Microsatellite instability (MSI) and loss of heterozygosity (LOH) in CDH1 were studied using D16S421, D16S496, D16S503, D16S512, D16S2624, and D16S3021 microsatellite markers and D2S123 (2p16), D2S382 (2q24), D6S292 (6q21–23), D7S480 (7q31), and D17S796 (17p13.1–3) were used to investigate genomic instability at 2p, 2q, 6q, 7q, and 17p loci in 40 GBC, 50 CC, 34 XGC, and 15 normal GB cases. Immunohistochemistry was carried out to analyze the E-cadherin and p53 protein expression. Overall LOH in CDH1 and other markers was high in GBC and XGC as compared to CC; however, it did not correlate with its protein expression in GBC cases. Loss of E-cadherin expression was high in GBC (67%), while majority of the CC (94%) and XGC (91%) cases retained positive E-cadherin expression. Overexpression of p53 was high in GBC (43%) whereas CC, XGC, normal GB cases were negative for p53 overexpression. None of the normal GB cases showed genomic instability at any of the markers. High LOH in CDH1 and other chromosomal loci in GBC indicated that the genomic instability followed a GBC>XGC>CC trend during the process of neoplastic transformation in GB, highlighting the fact that CC might act as a precursor lesion of GBC.

Kapoor VK, McMichael AJ (2003) Gallbladder cancer: an ‘Indian’ disease. Natl Med J India 16:209–213PubMed

Dhir V, Mohandas KM (1999) Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas. Indian J Gastroenterol 18:24–28PubMed

Silk YN, Douglass HO Jr, Nava HR et al (1989) Carcinoma of the gallbladder. The Roswell Park experience. Ann Surg 210:751–757CrossRefPubMed

Berx G, Staes K, van Hengel J et al (1995) Cloning and characterization of the human invasion suppressor gene E-cadherin (E-cadherin). Genomics 26:281–289CrossRefPubMed

Puhalla H, Herberger B, Soleiman A et al (2005) E-cadherin and β-catenin expression in normal, inflamed and cancerous gallbladder tissue. Anticancer Res 6:4249–4254

Fleming ID, Phillips JL, Menck HR et al (1997) The National Cancer Data Base report on recent hospital cancer program progress toward complete American Joint Committee on Cancer/TNM staging. Cancer 80:2305–2310CrossRefPubMed

Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257PubMed

Chaube A, Tewari M, Garbyal RS et al (2006) Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients. BMC Cancer 6:126CrossRefPubMed

Misra S, Chaturvedi A, Goel MM et al (2000) Overexpression of p53 protein in gallbladder carcinoma in North India. Eur J Surg Oncol 26:164–167CrossRefPubMed

10.

Balaram P, Alex S, Panikkar B et al (2004) Adhesion-related proteins E-cadherin, P-cadherin, CD44, and CD44v6, and antimetastatic protein nm23H1 in complete hydatidiform moles in relation to invasion potential. Int J Gynecol Cancer 14:532–539CrossRefPubMed

11.

Priya TP, Kapoor VK, Krishnani N et al (2009) Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer. Cancer Invest 27:764–773CrossRefPubMed

12.

Ito H, Matros E, Brooks DC et al (2004) Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience. J Gastrointest Surg 8:183–190CrossRefPubMed

13.

Zhang SH, Cong WM, Xian ZH et al (2005) Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China. World J Gastroenterol 11:3034–3039PubMed

14.

Pecina-Slaus N, Kljaic M, Nikuseva-Martic T (2005) Loss of heterozygosity of APC and CDH1 genes in laryngeal squamous cell carcinoma. Pathol Res Pract 201:557–563CrossRefPubMed

15.

Wei Y, Van Nhieu JT, Prigent S et al (2002) Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology 36:692–701CrossRefPubMed

16.

Moreno-Bueno G, Hardisson D, Sarrio D et al (2003) Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J Pathol 199:471–478CrossRefPubMed

17.

Grady WM, Willis J, Guilford PJ et al (2000) Methylation of the promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26:16–17CrossRefPubMed

18.

Soares P, Berx G, van Roy F et al (1997) E-cadherin gene alterations are rare events in thyroid tumors. Int J Cancer 70:32–38CrossRefPubMed

19.

Cheng CW, Wu PE, Yu JC et al (2001) Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 20:3814–3823CrossRefPubMed

20.

Bukholm IK, Nesland JM, Karesen R et al (1997) Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas. Virchows Arch 431:317–321CrossRefPubMed

21.

Stocklein H, Smardova J, Macak J et al (2008) Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma. Oncogene 27:2613–2625CrossRefPubMed

22.

Karabulut Z, Besim H, Hamamci O et al (2003) Xanthogranulomatous cholecystitis. Retrospective analysis of 12 cases. Acta Chir Belg 103:297–299PubMed

23.

Hofseth LJ, Khan MA, Ambrose M et al (2003) The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J Clin Invest 112:1887–1894PubMed

24.

Yanagisawa N, Mikami T, Yamashita K et al (2003) Microsatellite instability in chronic cholecystitis is indicative of an early stage in gallbladder carcinogenesis. Am J Clin Pathol 120:413–417CrossRefPubMed

25.

Schottenfeld D, Beebe-Dimmer J (2006) Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56:69–83CrossRefPubMed

26.

Tazuma S, Kajiyama G (2001) Carcinogenesis of malignant lesions of the gallbladder. The impact of chronic inflammation and gallstones. Langenbeck’s Arch Surg 386:224–229CrossRef

Title: Role of E-cadherin gene in gall bladder cancer and its precursor lesions
Authors: T. Padma Priya
V. K. Kapoor
N. Krishnani
Vinita Agrawal
Suraksha Agrawal
Publication date: 01-05-2010
Publisher: Springer-Verlag
Published in: Virchows Archiv / Issue 5/2010
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-010-0908-6

At a glance: The STEP trials

Springer Medicine

Role of E-cadherin gene in gall bladder cancer and its precursor lesions

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2010

Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas

Mitochondrion-rich differentiated adenocarcinomas of the stomach: clinicopathological, immunohistochemical and electron microscopy study of nine cases

Microsatellite instability of the colorectal carcinoma can be predicted in the conventional pathologic examination. A prospective multicentric study and the statistical analysis of 615 cases consolidate our previously proposed logistic regression model

Clinico-pathological features of breast myxoma: report of a case with histogenetic considerations

Decidual vascular patterns in first-trimester abortions

Amyloid in endomyocardial biopsies